Concepedia

Hematologic Malignancy Risk

Hematologic Malignancy Risk is a prognostic construct that quantifies the likelihood of tumor lysis syndrome development in patients with hematologic cancers based on the inherent biological aggressiveness, tumor burden, and treatment sensitivity of their underlying malignancy.

218

Publications

19.8K

Citations

1.9K

Authors

760

Institutions

Publications per year

2017–2026

68

Parents

Publications

218

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese, Anna K. Kähler, Robert E. Handsaker et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text

, , +16

Increased Risk of Lymphoma in Sicca Syndrome

Stuart S. Kassan · Annals of Internal Medicine · 1978 · 1K citations

, , +9

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

Milena Sant, Claudia Allemani, Carmen Ţereanu et al. · Blood · 2010 · 958 citations · Full text

, , +16

Risks of leukaemia and solid tumours in individuals with Down's syndrome

Henrik Hasle, Inge Clemmensen, Margareta Mikkelsen · The Lancet · 2000 · 896 citations

, , +12

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

Stanton Goldman, John S. Holcenberg, Jerry Z. Finklestein et al. · Blood · 2001 · 476 citations · Full text

, , +13

1–5 of 218

Authors

1.9K

  1. PV
    Paolo Vineis

    Imperial College London, United Kingdom

    6 publications · 435 citations

    6

    h-index

  2. OL
    Ola Landgren

    National Cancer Institute, United States

    6 publications · 635 citations

    6

    h-index

  3. LM
    Lucia Miligi

    Piedmont Reference Center for Epidemiology and Cancer Prevention, Italy

    5 publications · 318 citations

    5

    h-index

  4. LR
    Lynn R. Goldin

    National Cancer Institute, United States

    5 publications · 550 citations

    5

    h-index

  5. RM
    Ruth M. Pfeiffer

    National Cancer Institute, United States

    5 publications · 647 citations

    5

    h-index

1–5 of 1.9K

Institutions

760

  1. Karolinska Institutet

    Stockholm, Sweden

    14 h-index

    62 publications

    25.7K citations

  2. Lund University

    Lund, Sweden

    12 h-index

    29 publications

    4.1K citations

  3. National Cancer Institute

    Bethesda, United States

    11 h-index

    33 publications

    2.9K citations

  4. Johns Hopkins University

    Baltimore, United States

    9 h-index

    31 publications

    4.4K citations

  5. Karolinska University Hospital

    Stockholm, Sweden

    8 h-index

    24 publications

    7.5K citations

  6. The University of Texas MD Anderson Cancer Center

    Houston, United States

    8 h-index

    43 publications

    6K citations

  7. Northwestern University

    Evanston, United States

    8 h-index

    16 publications

    1.2K citations

  8. University of Turin

    Turin, Italy

    8 h-index

    11 publications

    580 citations

1–8 of 760

Venues

  1. PubMed

    Repository · 20 publications · 1K citations

    16

    h-index

  2. British Journal of Haematology

    BJH · 12 publications · 890 citations

    12

    h-index

  3. Blood

    10 publications · 2.3K citations

    10

    h-index

  4. Journal of Clinical Oncology

    9 publications · 1.3K citations

    9

    h-index

  5. Leukemia & lymphoma/Leukemia and lymphoma

    10 publications · 447 citations

    9

    h-index

1–5